Matrix Metalloproteinase Inhibitors: A Structure−Activity Study
- 1 January 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (2) , 199-223
- https://doi.org/10.1021/jm970494j
Abstract
Modifications around the dipeptide-mimetic core of a hydroxamic acid based matrix metalloproteinase inhibitor were studied. These variations incorporated a variety of natural, unnatural, and synthetic amino acids in addition to modifications of the P1' and P3' substituents. The results of this study indicate the following structural requirements: (1) Two key hydrogen bonds must be present between the enzyme and potent substrates. (2) Potent inhibitors must possess strong zinc-binding functionalities. (3) The potential importance of the hydrophobic group at position R3 as illustrated by its ability to impart greater relative potency against stromelysin when larger hydrophobic groups are used. (4) Requirements surrounding the nature of the amino acid appear to be more restrictive for stromelysin than for neutrophil collagenase, 72 kDa gelatinase, and 92 kDa gelatinase. These requirements may involve planar fused-ring aryl systems and possibly hydrogen-bonding capabilities.Keywords
This publication has 33 references indexed in Scilit:
- Inhibition of Stromelysin-1 (MMP-3) by P1‘-Biphenylylethyl Carboxyalkyl DipeptidesJournal of Medicinal Chemistry, 1997
- Rapid synthesis of novel dipeptide inhibitors of human collagenase and gelatinase using solid phase chemistryBioorganic & Medicinal Chemistry Letters, 1996
- Matrix Metalloproteinases, Gelatinase and Collagenase, in Chronic Leg UlcersJournal of Investigative Dermatology, 1996
- Determination of metalloproteinases, plasminogenactivators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesisClinica Chimica Acta; International Journal of Clinical Chemistry, 1996
- Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase BJournal of Bone and Mineral Research, 1996
- Synthesis of thiophenol derivatives as inhibitors of human collagenaseBioorganic & Medicinal Chemistry Letters, 1995
- Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790Inflammation Research, 1995
- Synthesis and Structure-Activity Relationships of Gelatinase Inhibitors Derived from Matlystatins.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
- Plasma Assay of Matrix Metalloproteinases (MMPs) and MMP-Inhibitor Complexes in Cancer.Annals of the New York Academy of Sciences, 1994
- A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinasesFEBS Letters, 1992